Pharmafile Logo

Dedicated

Allergan logo

Allergan and Gedeon finally get antipsychotic green light

Antipsychotic drug Vryalar launches into increasingly competitive market

Bristol-Myers Squibb (BMS) building

Opdivo a breakthrough in kidney cancer, says FDA

BMSmoves closer to US approval of its checkpoint inhibitor cancer immunotherapy

- PMLiVE

Jardiance survival data wows diabetes conference

BoehringerIngelheim and Eli Lilly release top-line findings from landmark trial at EASD

- PMLiVE

Yolo Communications forms social media partnership

Will work with Bakamo.Social on uncovering insightsfrom conversations

- PMLiVE

Counting down to the EFPIA Disclosure Code

Communications director Andy Powrie-Smith on why the Code is part of pharma's 'licence to operate'

- PMLiVE

Changing behaviours begins at home

Pharma companies and agencies alike may need to adapt their own behaviours to deliver healthcare communications that are fit for the future

- PMLiVE

Andy Grigg joins Bedrock to head up medical communications

He comes to the UK agency from Inspired Science

Pharma deals in August 2015

During a busy month AstraZeneca, Sanofi and Shire were among those hitting the headlines

- PMLiVE

Could EFPIA’s new code boost pharma’s reputation?

Rule changes for payments to doctors could present the industry with an opportunity

- PMLiVE

Omnicom combines BBDO, DDB and TBWA studio teams

New York departments will operate as part of the eg+network

- PMLiVE

Med comms agency Couch rebrands

Comes as the Manchester-based shop marks its second birthday

- PMLiVE

Digital technology and patient support

Programmes that improve outcomes are a key area for pharma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links